610 related articles for article (PubMed ID: 11125298)
1. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
2. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
[TBL] [Abstract][Full Text] [Related]
3. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
4. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains.
Takaoka A; Mitani Y; Suemori H; Sato M; Yokochi T; Noguchi S; Tanaka N; Taniguchi T
Science; 2000 Jun; 288(5475):2357-60. PubMed ID: 10875919
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activities of the soluble extracellular domains of type I interferon receptors.
Han CS; Chen Y; Ezashi T; Roberts RM
Proc Natl Acad Sci U S A; 2001 May; 98(11):6138-43. PubMed ID: 11344274
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.
Yan H; Krishnan K; Greenlund AC; Gupta S; Lim JT; Schreiber RD; Schindler CW; Krolewski JJ
EMBO J; 1996 Mar; 15(5):1064-74. PubMed ID: 8605876
[TBL] [Abstract][Full Text] [Related]
7. Direct signal transduction via functional interferon-alphabeta receptors in CD34+ hematopoietic stem cells.
Giron-Michel J; Weill D; Bailly G; Legras S; Nardeux PC; Azzarone B; Tovey MG; Eid P
Leukemia; 2002 Jun; 16(6):1135-42. PubMed ID: 12040445
[TBL] [Abstract][Full Text] [Related]
8. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
9. Dimerization of a chimeric CD4-interferon-alpha receptor reconstitutes the signaling events preceding STAT phosphorylation.
Krishnan K; Yan H; Lim JT; Krolewski JJ
Oncogene; 1996 Jul; 13(1):125-33. PubMed ID: 8700538
[TBL] [Abstract][Full Text] [Related]
10. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities.
Subramaniam PS; Khan SA; Pontzer CH; Johnson HM
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12270-4. PubMed ID: 8618883
[TBL] [Abstract][Full Text] [Related]
11. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
Colamonici O; Yan H; Domanski P; Handa R; Smalley D; Mullersman J; Witte M; Krishnan K; Krolewski J
Mol Cell Biol; 1994 Dec; 14(12):8133-42. PubMed ID: 7526154
[TBL] [Abstract][Full Text] [Related]
12. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling.
Li X; Leung S; Kerr IM; Stark GR
Mol Cell Biol; 1997 Apr; 17(4):2048-56. PubMed ID: 9121453
[TBL] [Abstract][Full Text] [Related]
13. The proximal tyrosines of the cytoplasmic domain of the beta chain of the type I interferon receptor are essential for signal transducer and activator of transcription (Stat) 2 activation. Evidence that two Stat2 sites are required to reach a threshold of interferon alpha-induced Stat2 tyrosine phosphorylation that allows normal formation of interferon-stimulated gene factor 3.
Nadeau OW; Domanski P; Usacheva A; Uddin S; Platanias LC; Pitha P; Raz R; Levy D; Majchrzak B; Fish E; Colamonici OR
J Biol Chem; 1999 Feb; 274(7):4045-52. PubMed ID: 9933596
[TBL] [Abstract][Full Text] [Related]
14. Stat2 binding to the interferon-alpha receptor 2 subunit is not required for interferon-alpha signaling.
Nguyen VP; Saleh AZ; Arch AE; Yan H; Piazza F; Kim J; Krolewski JJ
J Biol Chem; 2002 Mar; 277(12):9713-21. PubMed ID: 11786546
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
[TBL] [Abstract][Full Text] [Related]
16. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
17. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
18. Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex.
Yokota S; Saito H; Kubota T; Yokosawa N; Amano K; Fujii N
Virology; 2003 Feb; 306(1):135-46. PubMed ID: 12620806
[TBL] [Abstract][Full Text] [Related]
19. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway.
You M; Yu DH; Feng GS
Mol Cell Biol; 1999 Mar; 19(3):2416-24. PubMed ID: 10022928
[TBL] [Abstract][Full Text] [Related]
20. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection.
Lin RJ; Liao CL; Lin E; Lin YL
J Virol; 2004 Sep; 78(17):9285-94. PubMed ID: 15308723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
